TEK and cancer: Recently an in vitro study proposed that modulation of Tie2+ proangiogenic macrophages through rebastinib, could possibly control tumor angiogenesis and lymphangiogenesis involved in cancer cell intravasation and metastasis in a model of pNENs (71).